We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Infectious Disease Diagnostics – Products

Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in UK COVID-19 Human Challenge Study content piece image
Product News

Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in UK COVID-19 Human Challenge Study

Oxford Immunotec has announced that its T-SPOT® Discovery SARS-CoV-2 kit is being used for T cell testing in the UK COVID-19 Human Challenge Study, a national collaboration including the UK government, the NHS, academia and the private sector.
UK Diagnostic Company Collaborates With UK COV-AD Trial content piece image
Product News

UK Diagnostic Company Collaborates With UK COV-AD Trial

Oxford Immunotec has announced that its T-SPOT®.COVID test will be used for T cell testing in the COV-AD (COVID infection in patients with Antibody Deficiency) study in collaboration with the University of Birmingham.
Bio-Rad Launches Its Reliance SARS-CoV-2 RT-PCR Assay Kit in Europe content piece image
Product News

Bio-Rad Launches Its Reliance SARS-CoV-2 RT-PCR Assay Kit in Europe

Bio-Rad Laboratories, Inc. has announced the launch of the Reliance SARS-CoV-2 RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.
UK Diagnostic Company Collaborates With UK Com-COV Vaccine Trial content piece image
Product News

UK Diagnostic Company Collaborates With UK Com-COV Vaccine Trial

Oxford Immunotec has announced that its T-SPOT® Discovery SARS-CoV-2 kit will be used for T cell testing in the UK Com-COV trial.
Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test content piece image
Product News

Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Avacta Group plc has announced positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test.
AnteoTech Secures CE Certification for Its Versatile EuGeni Rapid Diagnostic Platform content piece image
Product News

AnteoTech Secures CE Certification for Its Versatile EuGeni Rapid Diagnostic Platform

AnteoTech has announced that its EuGeni™ Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received Conformité Européene (CE) Mark registration as the company looks to progress with European distribution.
Mologic’s COVID-19 Rapid Antigen Self-Test Selected by NIH for RADx Initiative Funding content piece image
Product News

Mologic’s COVID-19 Rapid Antigen Self-Test Selected by NIH for RADx Initiative Funding

Mologic has announced that its rapid antigen self-test for COVID-19 has been selected by the Rapid Acceleration of Diagnostics initiative launched by the U.S. National Institutes of Health. The initiative aims to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.
Thermo Fisher Scientific Collaborates with Artificial To Accelerate COVID-19 Diagnostics content piece image
Product News

Thermo Fisher Scientific Collaborates with Artificial To Accelerate COVID-19 Diagnostics

Thermo Fisher Scientific and Artificial have announced a collaboration to develop an integrated and comprehensive software automation platform for Thermo Fisher’s standardized COVID-19 Testing Platform. The integration will result in increased testing throughput and support global healthcare initiatives.
MicrosensDx RapiPRO™ LAMP for SARS-CoV-2 Receives CE Mark Approval content piece image
Product News

MicrosensDx RapiPRO™ LAMP for SARS-CoV-2 Receives CE Mark Approval

Pioneering British biotech MicrosensDx has announced that its RapiPRO™ LAMP SARS-CoV-2 test has received CE Certification.
Promega Launches XpressAmp™ Direct Amplification Reagents  content piece image
Product News

Promega Launches XpressAmp™ Direct Amplification Reagents

Promega Corporation has released XpressAmp™ Direct Amplification Reagents that facilitate RNA extraction-free sample preparation that is automation-friendly. With this innovation, laboratories testing for COVID-19 have a new tool that enables them to skip the potentially bottlenecked RNA extraction step of the workflow and move directly to polymerase chain reaction (PCR) amplification.
Advertisement